Health

  • August 19, 2026

    Outcome Health Execs Owe $270M And Counting For Fraud

    Former Outcome Health executives who were convicted of a $1 billion fraud against investors, lenders and customers must repay $270.8 million to certain victims, though that amount will climb higher with additional calculation, an Illinois federal judge said Wednesday.

  • August 19, 2026

    FTC Asks Court To Keep Trans Health Suit In Texas

    The Federal Trade Commission has asked a Texas federal court to keep its suit against the World Professional Association for Transgender Health in the Lone Star State, saying that the organization incorporated there in 1980.

  • August 19, 2026

    HHS, USDA Must Withdraw Dietary Guidelines, DC Court Told

    A public health nonprofit on Wednesday urged a D.C. federal court to order the federal government to withdraw dietary guidelines it issued earlier this year, arguing that reviewers who advised on the guidelines had significant conflicts of interest and were selected without public oversight.

  • August 19, 2026

    Medtronic, Former Exec Settle Whistleblower Retaliation Suit

    A Colorado state judge tossed a whistleblower lawsuit against Medtronic Inc., granting a dismissal bid from the company and a former executive after they reached an undisclosed settlement.

  • August 19, 2026

    6th Circ. Backs Blue Cross Over Reimbursement Rate Dispute

    The Sixth Circuit on Wednesday upheld Blue Cross Blue Shield of Michigan's defeat of a lawsuit alleging it shortchanged several medical providers despite promising higher reimbursement rates before a La-Z-Boy employee received care, ruling the providers' claims were superseded by federal benefits law.

  • August 19, 2026

    Mich. Judge Is Torn Over Data Tracking Suit

    A Michigan judge tasked with deciding whether to dismiss a proposed class action against state healthcare facilities alleging improper use of data tracking tools on Wednesday told attorneys that he could not remember a case in which supporting decisions were divided so evenly.

  • August 19, 2026

    Trump Taps White House Aide Overton To Lead FDA

    President Donald Trump on Wednesday announced the nomination of White House aide Heidi Overton, an abortion opponent who has urged states to roll back vaccine requirements, to lead the U.S. Food and Drug Administration.

  • August 19, 2026

    Bradley Arant Adds SCP Health In-House Vet In Atlanta

    Bradley Arant Boult Cummings LLP has added the senior vice president and associate general counsel of healthcare company SCP Health to its Atlanta office, strengthening the firm's healthcare practice.

  • August 19, 2026

    Rising Star: McGuireWoods' Kayla McCann Marty

    Kayla McCann Marty of McGuireWoods LLP helped guide United Urology Group through its undisclosed sale to OneOncology, and guided Novant Health through its acquisition of UCI Medical Affiliates from Blue Cross Blue Shield of South Carolina, earning her a spot among healthcare law practitioners under age 40 honored by Law360 as Rising Stars.

  • August 19, 2026

    Judge May Trim $88M Covidien Hernia Mesh Verdict

    A Massachusetts federal judge said Wednesday she is "likely" to reduce a jury's recent $88 million verdict in a bellwether hernia mesh lawsuit and encouraged lawyers for an Alabama couple and Covidien LP to consider a settlement.

  • August 19, 2026

    5th Circ. Backs Delay Of FDA's 11-Warning Cigarette Rule

    The Fifth Circuit on Tuesday upheld the delay of a U.S. Food and Drug Administration rule requiring the addition of graphic warning labels to cigarette packages, saying tobacco companies that challenged the rule showed the agency likely overstepped its narrow authority to adjust existing warnings by creating two new ones.

  • August 19, 2026

    Ga. Appeals Court Says Hospital Must Face Negligence Suit

    A Georgia hospital will have to face a woman's suit alleging her husband died because one of its employees dropped him during a bed transfer, the Georgia Court of Appeals said, faulting a trial court's ruling that she needed to file an expert affidavit.

  • August 18, 2026

    AAMC Gouges Med Residency Applicants, Antitrust Suit Says

    The Association of American Medical Colleges unlawfully monopolizes the market for medical residency and fellowship application platforms, charging aspiring doctors supracompetitive electronic application fees while "wildly" enriching the nonprofit's executives, a doctor alleged Tuesday in a proposed antitrust class action filed in D.C. federal court.

  • August 18, 2026

    At DC Circ., Pharma's Latest Pricing Loss Has Silver Linings

    The pharmaceutical industry's far-flung crusade against Medicare's new negotiation powers suffered a fresh setback Tuesday as the D.C. Circuit joined sister circuits in upholding the landmark pricing program, but the defeat contained consolation prizes that will fuel further litigation.

  • August 18, 2026

    Ex-NFL Player Sues Disability Benefits Plan Over Denial

    A former National Football League player who reportedly suffered brain injuries from nearly two decades of playing the sport hit the league's disability benefit plan with a lawsuit Tuesday, telling a Maryland federal judge that the plan wrongfully denied his application for total and permanent disability benefits despite his own doctor's diagnosis.

  • August 18, 2026

    DC Circ. Revives Part Of Fight Over Braille-Free Drug Label

    The D.C. Circuit on Tuesday partially vacated a lower court judgment that had upheld the U.S. Food and Drug Administration's approval of a label without braille for Teva Pharmaceuticals' generic version of a drug often prescribed to blind people.

  • August 18, 2026

    Ambulance Co. Says Insurers Failed To Settle Crash Claims

    A Pennsylvania ambulance service alleged in state court that its insurers refused to consider a settlement offer within its policy limits to resolve claims stemming from a fatal crash, exposing the company to a higher judgment after the crash victim's estate added punitive damages to the underlying case.

  • August 18, 2026

    Harvard To Pay $53M Over Medical School Morgue Thefts

    Harvard University has agreed to pay $53 million to settle more than a dozen consolidated lawsuits over the theft of body parts from its medical school morgue by a former manager, lawyers for the plaintiffs said Tuesday.

  • August 18, 2026

    Bot Errors Doom Expert's Credibility In Tainted-Supplement Suit

    A Washington federal judge Tuesday disposed of a U.S. Army nurse's lawsuit claiming supplement maker Thesis Nootropics sold products tainted with amphetamines, concluding that a key expert destroyed his credibility by submitting a report containing bot-generated false citations — much like errors for which the plaintiffs' counsel was recently sanctioned.

  • August 18, 2026

    Mich. Fights Atty Fee Demand in Newborn Blood Spot Lawsuit

    The state of Michigan told a federal judge on Tuesday that the $372,400 in legal fees requested by plaintiffs in a newborn blood spot lawsuit is "excessive" and that an award should be either delayed or significantly lowered.

  • August 18, 2026

    DEA Blasts Marijuana Foes' Objections To Rescheduling

    The U.S. Drug Enforcement Administration on Monday told an administrative law judge that federal restrictions should be loosened on marijuana and that opponents of cannabis reform brought a meritless challenge to health regulators' assessment of the drug's medical use.

  • August 18, 2026

    Orrick, Kirkland Steer Weave's $650M Take-Private

    Patient engagement platform and payment services company Weave Communications Inc., led by Orrick Herrington & Sutcliffe LLP, on Tuesday revealed it will become a private company after it was acquired by Kirkland & Ellis LLP-advised private equity shop Francisco Partners in a $650 million deal.

  • August 18, 2026

    Troutman Sidelined Associate After Heart Attack, Suit Says

    Troutman Pepper Locke LLP derailed an associate's career because he took medical leave to recover from a heart attack and spoke up about senior attorneys' fraudulent billing practices, according to a lawsuit filed Tuesday in New Jersey federal court.

  • August 18, 2026

    BioMarin Buying Alesta Therapeutics For Up To $490M

    Jones Day-advised BioMarin Pharmaceutical Inc. said Tuesday it has agreed to acquire Alesta Therapeutics for $275 million upfront and up to another $215 million tied to the development and regulatory progress of Alesta's lead drug candidate.

  • August 18, 2026

    11th Circ. Affirms Kickback Convictions For Pain Doc, Salesman

    The Eleventh Circuit on Tuesday affirmed the conviction and sentences of a Florida pain doctor and a salesman found guilty of participating in a kickback conspiracy for prescribing a fentanyl spray, ruling prosecutors had "overwhelming" evidence the men knowingly participated in "sham" drug promotion events.

Expert Analysis

  • Series

    Podcasting Makes Me A Better Lawyer

    Author Photo

    Podcasting has changed how I ask questions and connect with people, sharpening my ability to listen without interrupting or prejudging, and bringing me closer to what law is meant to be: a human profession grounded in understanding, judgment and trust, says Donna DiMaggio Berger at Becker.

  • When Fraud Involvement Disqualifies FCA Whistleblowers

    Author Photo

    A Massachusetts federal court's recent dismissal of a False Claims Act relator in U.S. ex rel. Perry v. First Psychiatric Planners provides instructive insight into when whistleblowers may be denied their share of settlement proceeds, even if their involvement in the underlying fraud is a step removed, say attorneys at Holland & Knight.

  • Job Shift Accommodation Ruling Clarifies 'Essential Function'

    Author Photo

    In Siebrecht v. Mercy Health-Iowa, the Eighth Circuit's recent denial of a disabled worker's shift exemption request shows that the essential function of a job can encompass more than core job requirements and include things like scheduling flexibility, says Kim Kirn at Miles Mediation & Arbitration.

  • Opinion

    Fed. Circ. Must Bury Design Patent Doctrinal Zombies

    Author Photo

    After recently finding noninfringement in Range of Motion Products v. Armaid, the Federal Circuit must rehear the case to confront two troublesome doctrines of design patent law claim construction — feature filtration and claim verbalization — that have lingered for decades and intensified in recent years, say attorneys at McAndrews Held.

  • H-1B Registration Tips For New Wage-Weighted Selection

    Author Photo

    Practitioners participating in this year’s H-1B visa registration, currently underway, must understand that under the new wage-weighted selection process that replaced the random lottery, the crucial first step is choosing the correct standard occupational classification, says Jimmy Lai at Lai & Turner.

  • Lessons From Justices' Split On Major Questions Doctrine

    Author Photo

    The justices' varied opinions in Learning Resources v. Trump, which held the International Emergency Economy Powers Act did not confer the power to impose tariffs, offer a meaningful window into the U.S. Supreme Court's perspective on the major questions doctrine that will likely shape lower courts' approach to executive action challenges, say attorneys at Venable.

  • Drug Wholesaler's DPA Shows Imperfect Efforts Still Count

    Author Photo

    Atlantic Biologicals’ recent deferred prosecution agreement with federal prosecutors for allegedly distributing controlled substances to pill mill pharmacies demonstrates that even subpar cooperation, when combined with genuine remediation and strategic advocacy, can yield outcomes that protect a company's long-term interests, says Jonathan Porter at Husch Blackwell.

  • Key Takeaways As HRSA Aims To Revive 340B Rebate Pilot

    Author Photo

    The U.S. Department of Health and Human Services' recent request for feedback on the 340B Rebate Model Pilot Program demonstrates that it intends to correct the model's procedural defects, which is positive news for participating manufacturers, but a setback for covered entities, say attorneys at Manatt.

  • Why Mukherji Won't End USCIS' EB-1A Two-Step

    Author Photo

    A Nebraska federal court's recent decision in Mukherji v. Miller seemed to vindicate longstanding complaints about the U.S. Citizenship and Immigration Services' controversial two-step adjudication process, declaring the framework unlawful — but Mukherji is unlikely to be the death blow that immigration practitioners have hoped for, says Jun Li at Reid & Wise.

  • Unique Issues Facing Brand-Compounder Patent Litigation

    Author Photo

    Recent litigation and potential enforcement action against Hims & Hers Health raise questions about how compounders and branded pharmaceuticals companies would be positioned in patent litigation as compared to generics companies, which would require strategies different from those that would be used in traditional Hatch-Waxman Act litigation, say attorneys at Morgan Lewis.

  • Series

    Volunteering With Scouts Makes Me A Better Lawyer

    Author Photo

    Serving as an assistant scoutmaster for my son’s troop reaffirmed several skills and principles crucial to lawyering — from the importance of disconnecting to the value of morality, says Michael Warren at McManis Faulkner.

  • Series

    Law School's Missed Lessons: In Court, It's About Storytelling

    Author Photo

    Law school provides doctrine, cases and hypotheticals, but when lawyers step into the courtroom, they must learn the importance of clarity, credibility, memorability and preparation — in other words, how to tell simple, effective stories, say Nicholas Steverson and Danielle Trujillo at Wheeler Trigg, and Lisa DeCaro at Courtroom Performance.

  • Pros And Cons Of FDA's Push For Nonprescription Drugs

    Author Photo

    The U.S. Food and Drug Administration's recent moves to shift more prescription drugs to over-the-counter status could increase access to important medications, but also bring potential safety risks and other trade-offs for drug companies, say attorneys at Hogan Lovells.

  • Prepping For The Future Of No Surprises Act Enforcement

    Author Photo

    This year is expected to be a transition point for the No Surprises Act framework from regulatory delay to operational enforcement, so stakeholders should use this time to stress-test systems, clean up processes and prepare for enforcement, say attorneys at Akerman.

  • High Court's 'Skinny Label' Case May Tackle Wider Questions

    Author Photo

    The U.S. Supreme Court's upcoming decision in Hikma v. Amarin will have important ramifications for broader debates over what defines a generic version of a drug, and the pending case is already altering patent practice, say attorneys at Taft.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.